Skip to main content
TipRanks
Go Ultimate75% OFF

Medigen Biotechnology Corporation (3176) Cash flow

Medigen Biotechnology Corporation Cash Flow

TW:3176's free cash flow for Q2 2026 was NT$-126.05M. For the 2026 fiscal year, TW:3176's free cash flow was decreased by NT$-46.66M and operating cash flow was NT$-79.39M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 49.03MNT$ 37.92MNT$ -503.52MNT$ -1.13BNT$ 517.45M
NT$ 44.34MNT$ 903.30MNT$ 497.66MNT$ -692.67MNT$ -369.75M
NT$ -157.26MNT$ -1.77BNT$ 193.15MNT$ 1.72BNT$ -209.29M
NT$ 1.32BNT$ 1.39BNT$ 2.22BNT$ 2.04BNT$ 2.14B
NT$ -22.41MNT$ -20.76MNT$ -545.42MNT$ -1.28BNT$ 372.90M

Currency in TWD

Medigen Biotechnology Corporation Cash Flow

-2B-1B01B2B3B201720182019202020212022202320242025OperatingInvestingFinancing